Facility
Civica Rx Petersburg Fill-Finish Facility
Civica's US fill-finish facility for insulin glargine biosimilar pens and vials. Drug substance imported from Biocon (India). Launched $45/box product in January 2026, disrupting the Big Three oligopoly pricing.
0
Inputs produced
0
Goods downstream
0
Incidents on record
0
Stories